DAINIPPON SUMITOMO PHARMA CO., LTD. : DSP and Takeda Announce …
DAINIPPON SUMITOMO PHARMA CO., LTD. : DSP and Takeda Announce …
Lurasidone, orally administrated once daily, is an atypical antipsychotic medication discovered and developed by DSP. In the U.S., it was approved for the treatment of schizophrenia and also for major depressive episodes associated with bipolar I … Read more on 4-traders (press release)
Tags: major depressive episode, treatment of schizophrenia